Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Allergy and Clinical Immunology|January 26, 2018
Basophils from allergic patients are neither hyperresponsive to activation signals nor hyporesponsive to inhibition signalsLydie Cassard, Katia Sperber, Tan-Phuc Buivan, et al.
Blood|May 28, 2009
Type 17 CD8+ T cells display enhanced antitumor immunityChristian S Hinrichs, Andrew Kaiser, Chrystal M Paulos, et al.
The Journal of Clinical Investigation|November 20, 2002
Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cellsLydie Cassard, Joël F G Cohen-Solal, Annie Galinha, et al.
Cancers|December 8, 2020
Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung CancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
Clinical Immunology (Orlando, Fla.)|January 10, 2015
Semi-automated and standardized cytometric procedures for multi-panel and multi-parametric whole blood immunophenotypingMilena Hasan, Benoit Beitz, Vincent Rouilly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2016
IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 AntagonistsMélanie Desbois, Pauline Le Vu, Clélia Coutzac, et al.
Lung Cancer (Amsterdam, Netherlands)|December 26, 2021
Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trialMariona Riudavets, Marie Naigeon, Matthieu Texier, et al.
Journal for Immunotherapy of Cancer|February 8, 2022
CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockersBoris Duchemann, Marie Naigeon, Edouard Auclin, et al.
Nature Medicine|June 16, 2009
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cellsLuca Gattinoni, Xiao-Song Zhong, Douglas C Palmer, et al.
Pageof 5